Thank you, Betsy, and good morning, everyone. Welcome to Truist's First Quarter 2025 Earnings Call. With us today are our Chairman and CEO, Bill Rogers; our CFO, Mike Maguire; our Chief Risk Officer, ...

Natasha Cazenave, executive director of the European Securities and Markets Authority (ESMA), addressed the European ...

Advancing development of next-generation precision Antibody Drug Conjugates (ADCs) to address multiple indications across a range of cancer types ...

Revenue and Sales Performance: For the fiscal third quarter of 2025, Biomerica reported net sales of $1.10 million, a 10% increase from $1.00 million recorded in the same quarter of the previous year.